Adding triglyceride-lowering Omega-3 based medication to statins may lower stroke risk

Adding the triglyceride-lowering medication icosapent ethyl cut the risk of a first stroke by an additional 36% in patients already taking statin medications to treat high cholesterol. In previous research, icosapent ethyl reduced the risk of major cardiovascular events. The prescription medication is a highly purified form of an omega-3 fatty acid. The study’s results do not apply to supplements available over-the-counter. View original article here Source

Related Posts